Societe Adwya SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Societe Adwya SA with three other
pharmaceutical manufacturers in Africa:
Unite de Fabrication de Medicaments SA
sales of 107.21 million Tunisian Dinars [US$37.06 million]
Fidson Healthcare Limited
(14.06 billion Nigerian Naira [US$38.95 million]
May & Baker Nigeria Plc.
based in NIGERIA
(8.08 billion Nigerian Naira [US$22.38 million]
Societe Adwya SA reported sales of 105.64 million Tunisian Dinars (US$36.51 million)
December of 2019.
decrease of 2.3%
versus 2018, when the company's sales were 108.18 million Tunisian Dinars.
Contributing to the drop in overall sales was the 37.9% decline
in Hospital, from 3.83 million Tunisian Dinars to 2.38 million Tunisian Dinars.
There were also decreases in sales in
Pharmacy (down 4.6% to 60.62 million Tunisian Dinars)
However, these declines were partially offset by the increase in sales of
Adwya Products (up 1.7% to 39.65 million Tunisian Dinars)
Export (up 131.0% to 1.65 million Tunisian Dinars)
Manufacturingd/tailored Products (up 25.8% to 1.09 million Tunisian Dinars)
Shopping and Other Services (up 9.3% to 154,651.00 Tunisian Dinars)
Samples (up 7.5% to 95,843.00 Tunisian Dinars)